Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
With Two More Completions, Personal Genomics Picks up Speed
12 November 2008. An exceedingly exclusive club recently welcomed two new members, with the publication of the complete genome sequences of an African and a Chinese man in the November 6 issue of Nature. That brings to four the number of people who have had their personal genetic code read in its entirety. James Watson, co-discoverer of the double helix, and sequencing pioneer Craig Venter were the first two. Now, they are joined by a pair of anonymous individuals, as a group led by David Bentley of Illumina Cambridge Ltd. in Essex, UK, reports the complete genome of a Nigerian man, while Jun Wang, Jian Wang and colleagues from Shenzhen University, China, release the genetic makeup of a Han Chinese man. No women in the club as of yet.

The new genomes were accomplished in a fraction of the time and cost of the Watson and Venter efforts, and the accomplishment moves researchers one step closer to the goal of routine personal genome sequencing for medical and research purposes.

Both groups used massively parallel chip-based sequencing techniques that can produce 100 million short 35 base-pair sequences at one time. Using multiple chips, the groups generated between 4 and 17 billion bases worth of sequence data per week (the complete human genome has about three billion bases). The short reads were assembled using the existing reference genome as a template. In eight weeks, at a cost of $250,000 for reagents, the Bentley team produced 135 billion bases of sequence, an average 40-fold coverage of the genome. The Wang team had comparable output at a price they put at less than $500,000. For comparison, Watson’s genome cost $10 million to complete, at 7.5-fold coverage.

Because of the high coverage rate, the sequences were highly accurate. For example, 99 percent of the roughly 3 million known single nucleotide polymorphisms (SNPs) were confirmed, and an additional million more SNPs were identified. The incidence of insertions and deletions was similar to that seen with the previous work, although the technique preferentially detected deletions and small insertions.

“The approach of Bentley, Wang and their colleagues represents a substantial advance in the sequencing of individual genomes,” write Samuel Levy and Robert Strausberg of the J. Craig Venter Institute of Rockville, Maryland, in an accompanying commentary. “They reinforce the catalog of variants that exist in human genomes—SNPs in the millions, insertion/deletion polymorphisms in the hundreds of thousands and structural variants in the thousands.”

Interestingly, the Chinese man appears to have an elevated risk for Alzheimer disease based on his APOE and SORL1 alleles, but there is no family information available that might indicate a history of AD. Assigning risk using known genes is one important application of personal genomics. Another is using genotype-phenotype associations to uncover genes and variants associated with disease, an effort that will depend on having many more individual genomes. With both the Chinese and British groups participating in the 1000 Genomes Project, the "completely sequenced" club might be looking at a major boost in membership soon.—Pat McCaffrey.

References
Bentley DR, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008 Nov 6;456(7218):53-9. Abstract

Wang J, et al. The diploid genome sequence of an Asian individual. Nature. 2008 Nov 6;456(7218):60-5. Abstract

Levy S, Strausberg RL. Human genetics: Individual genomes diversify. Nature. 2008 Nov 6;456(7218):49-51. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad